about
Protocol: Evaluating the impact of a nation-wide train-the-trainer educational initiative to enhance the quality of palliative care for children with cancer.Most children with cancer are not enrolled on a clinical trial in Canada: a population-based study.Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort studyThe Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia.Low socioeconomic status is associated with worse survival in children with cancer: a systematic reviewA population based perspective on children and youth with brain tumoursPaediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines.Children and youth with non-traumatic brain injury: a population based perspectiveThe validity of pediatric cancer diagnoses in a population-based general cancer registry in Ontario, Canada.The Validity of Using Health Administrative Data To Identify the Involvement of Specialized Pediatric Palliative Care Teams in Children with Cancer in Ontario, Canada.Cancer Survival Disparities Between First Nation and Non-Aboriginal Adults in Canada: Follow-up of the 1991 Census Mortality Cohort.Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancer.Validity of Administrative Data in Identifying Cancer-related Events in Adolescents and Young Adults: A Population-based Study Using the IMPACT Cohort.Diagnostic and Treatment Patterns Among Children, Adolescents, and Young Adults with Thyroid Cancer in Ontario: 1992-2010.Predictors of diagnostic interval and associations with outcome in acute lymphoblastic leukemia.Inferior survival among Aboriginal children with cancer in Ontario.Early deaths in pediatric acute leukemia: a population-based study.Instruments to measure anxiety in children, adolescents, and young adults with cancer: a systematic review.Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer.Specialized survivor clinic attendance is associated with decreased rates of emergency department visits in adult survivors of childhood cancer.Differential survival improvement for patients 20-29 years of age with acute lymphoblastic leukemia.LG-03RADIATION THERAPY IS ASSOCIATED WITH INCREASED LATE MORTALITY IN LONG-TERM ADULT SURVIVORS OF CHILDHOOD LOW GRADE GLIOMA: A POPULATION BASED STUDY.LG-01BRAF MUTATION AND CDKN2A DELETION DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH-GRADE GLIOMA.LG-66CLINICAL AND TREATMENT FACTORS DETERMINING LONG-TERM OUTCOMES FOR ADULT SURVIVORS OF CHILDHOOD LOW-GRADE GLIOMA: A POPULATION-BASED STUDY.The Impact of School Visits on Siblings of Children With Cancer.Maternal outcomes associated with weight change between pregnancies.Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study.A systematic review and meta-analysis of the association between childhood infections and the risk of childhood acute lymphoblastic leukaemia.Predictors of Specialized Pediatric Palliative Care Involvement and Impact on Patterns of End-of-Life Care in Children With Cancer.Treatment-related mortality in newly diagnosed pediatric cancer: a population-based analysis.Adverse mental health outcomes in a population-based cohort of survivors of childhood cancer.Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.Late mortality after hematopoietic SCT for a childhood malignancy.Enrollment on clinical trials does not improve survival for children with acute myeloid leukemia: A population-based studyDiabetes Risk in Childhood Cancer Survivors: A Population-Based StudyUse of physician billing claims to identify infections in childrenThe Australian-Canadian Adolescent and Young Adult Collaborative Cohort Initiative: Initial Meeting ReportNational Impact of the EPEC-Pediatrics Enhanced Train-the-Trainer Model for Delivering Education on Pediatric Palliative Care
P50
Q27309024-2F8BA089-3858-4CE1-8A30-1821BAB20725Q33767843-2AD9AB20-636A-47DD-ABD9-99C74633D209Q33869184-CFC1FD51-A1AD-4623-80CC-791C3F362711Q34491288-DDB5B544-364D-4402-BDDF-E7CC7A503C5FQ34747454-6AF127A9-11A2-4AD9-83E5-1AC214D91156Q35107431-099FD019-CC45-4F15-BF64-4AD3342F0B44Q35877187-472903AE-886D-4462-97F3-4D38643146D2Q36051934-BD8BC239-0F04-410F-B420-31428F73E4FCQ36083294-98F812C8-81C9-4959-9A0C-768B3825F771Q36191920-D0874FE8-E677-4280-B94D-C1B52B1B4276Q36396069-0AA5C3AD-A506-450D-B73C-75D11B365DD7Q38383497-996549F1-B8E6-4BAC-9595-99869ABAFF73Q38617723-A5F40D9D-8A13-49FE-9F1B-57795A10DA2EQ38635588-D789BB46-2FEA-4B9C-AD2E-6A9F35A5FF45Q38668033-A02E89D8-98C2-4907-AFC4-89DB7706A099Q38780714-6356BDD3-3D71-48A7-8411-D6723012B8C7Q39059553-8E32F8EB-7B5E-4A67-9F22-0ADCD2725F31Q39193176-876C13A1-8CD3-4D09-BB90-C3AAB68F4479Q39340123-C045F35F-6FD3-42FD-A6A9-A4F1FDF53D97Q39348775-F0D3290A-09D3-42D6-BC87-C335DAF30BA1Q40003525-45E41954-07C0-43DA-86BD-875C8BA42376Q40500988-7DC63A4E-E09A-42DC-A7DD-8FA932208DC1Q44627951-A7D052A0-EA19-4085-BC58-CBC3B0E43B26Q45956273-2A07E8E0-9308-4EE4-8E12-42440F231BA9Q45956302-B371ED3F-689B-4E93-908F-28E2C68C866BQ46353723-E332DE1F-77B5-4BF3-ADB6-9365590FECA9Q47222877-803FFB28-5572-405D-96A6-BB82986985ABQ47257442-0C8F92AA-E947-4E9B-BCBD-A3B7D3983691Q47704477-5775B315-60E4-40B0-BE58-A9D8B0377D57Q47729300-D1DF9E5B-624D-4364-8F66-37FFFD8B2CE2Q50111113-E108A45D-1DAC-4239-B2D0-00362A1272E4Q50422207-7C5611EE-DC76-488D-9FB3-4708E3416156Q52315673-58F14F01-271B-46CC-BD48-D628977F06E2Q52964863-92611C8A-CD76-44BF-812C-7153CF0A01E2Q53107532-D393CD27-5092-4E47-AF7D-290006A33B76Q57020360-B645A13C-A0F6-42C8-912A-1DA36604F345Q57135163-EACC3C5E-32B6-46EF-9F1F-36575B2CA613Q59136807-43A92178-3DE1-448D-A03F-5CDC128E3E7FQ60310735-AA02032B-2260-46B2-8D95-A5EC0C66F220Q88755226-C91BC30D-A4E0-46D7-A46F-4458C82F25DA
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jason D Pole
@en
Jason D Pole
@nl
type
label
Jason D Pole
@en
Jason D Pole
@nl
prefLabel
Jason D Pole
@en
Jason D Pole
@nl
P31
P496
0000-0002-0413-5434